| Product Code: ETC12923225 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Androgen Deprivation Therapy Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Androgen Deprivation Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Androgen Deprivation Therapy Market - Industry Life Cycle |
3.4 Mexico Androgen Deprivation Therapy Market - Porter's Five Forces |
3.5 Mexico Androgen Deprivation Therapy Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
3.6 Mexico Androgen Deprivation Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Mexico Androgen Deprivation Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Mexico Androgen Deprivation Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Androgen Deprivation Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of prostate cancer in Mexico |
4.2.2 Rising awareness about advanced treatment options for prostate cancer |
4.2.3 Growing geriatric population in Mexico |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of androgen deprivation therapy drugs in Mexico |
4.3.2 High cost associated with androgen deprivation therapy treatment |
4.3.3 Potential side effects and risks associated with long-term use of androgen deprivation therapy drugs |
5 Mexico Androgen Deprivation Therapy Market Trends |
6 Mexico Androgen Deprivation Therapy Market, By Types |
6.1 Mexico Androgen Deprivation Therapy Market, By Therapeutic Class |
6.1.1 Overview and Analysis |
6.1.2 Mexico Androgen Deprivation Therapy Market Revenues & Volume, By Therapeutic Class, 2021 - 2031F |
6.1.3 Mexico Androgen Deprivation Therapy Market Revenues & Volume, By LHRH Agonists, 2021 - 2031F |
6.1.4 Mexico Androgen Deprivation Therapy Market Revenues & Volume, By Antiandrogens, 2021 - 2031F |
6.2 Mexico Androgen Deprivation Therapy Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Mexico Androgen Deprivation Therapy Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.2.3 Mexico Androgen Deprivation Therapy Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.4 Mexico Androgen Deprivation Therapy Market Revenues & Volume, By Transdermal, 2021 - 2031F |
6.3 Mexico Androgen Deprivation Therapy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Mexico Androgen Deprivation Therapy Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.4 Mexico Androgen Deprivation Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Mexico Androgen Deprivation Therapy Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.4.3 Mexico Androgen Deprivation Therapy Market Revenues & Volume, By Online Sales, 2021 - 2031F |
7 Mexico Androgen Deprivation Therapy Market Import-Export Trade Statistics |
7.1 Mexico Androgen Deprivation Therapy Market Export to Major Countries |
7.2 Mexico Androgen Deprivation Therapy Market Imports from Major Countries |
8 Mexico Androgen Deprivation Therapy Market Key Performance Indicators |
8.1 Patient survival rate post androgen deprivation therapy treatment |
8.2 Adoption rate of newer androgen deprivation therapy drugs in Mexico |
8.3 Average age of patients opting for androgen deprivation therapy |
8.4 Number of healthcare facilities offering androgen deprivation therapy treatments |
8.5 Rate of recurrence of prostate cancer post androgen deprivation therapy |
9 Mexico Androgen Deprivation Therapy Market - Opportunity Assessment |
9.1 Mexico Androgen Deprivation Therapy Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
9.2 Mexico Androgen Deprivation Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Mexico Androgen Deprivation Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Mexico Androgen Deprivation Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Androgen Deprivation Therapy Market - Competitive Landscape |
10.1 Mexico Androgen Deprivation Therapy Market Revenue Share, By Companies, 2024 |
10.2 Mexico Androgen Deprivation Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here